Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 12,225,000 | 15,121,000 | 14,812,000 | 14,583,000 | 13,538,000 |
| Cost of Goods | 3,986,000 | 4,170,000 | 5,022,000 | 4,170,000 | 4,052,000 |
| Gross Profit | 8,239,000 | 10,951,000 | 9,790,000 | 10,413,000 | 9,486,000 |
| Operating Expenses | 5,471,000 | 5,449,000 | 5,187,000 | 7,118,000 | 4,769,000 |
| Operating Income | 2,768,000 | 5,502,000 | 4,603,000 | 3,295,000 | 4,717,000 |
| Interest Expense | 454,000 | 476,000 | 497,000 | 532,000 | 539,000 |
| Other Income | -1,839,000 | -2,061,000 | 294,000 | -1,580,000 | 751,000 |
| Pre-tax Income | 475,000 | 2,965,000 | 4,400,000 | 1,183,000 | 4,929,000 |
| Income Tax | 234,000 | 493,000 | 448,000 | 255,000 | 436,000 |
| Net Income Continuous | 241,000 | 2,472,000 | 3,952,000 | 928,000 | 4,493,000 |
| Minority Interests | 2,000 | -1,000 | 3,000 | 4,000 | 3,000 |
| Net Income | $239,000 | $2,473,000 | $3,949,000 | $924,000 | $4,490,000 |
| EPS Basic Total Ops | 0.13 | 1.39 | 2.22 | 0.52 | 2.52 |
| EPS Basic Continuous Ops | 0.14 | 1.40 | 2.23 | 0.52 | 2.54 |
| EPS Diluted Total Ops | 0.13 | 1.40 | 2.21 | 0.51 | 2.51 |
| EPS Diluted Continuous Ops | 0.14 | 1.39 | 2.23 | 0.52 | 2.53 |
| EPS Diluted Before Non-Recurring Items | 2.46 | 3.60 | 3.66 | N/A | N/A |
| EBITDA(a) | $4,895,000 | $7,659,000 | $6,808,000 | $5,347,000 | $6,770,000 |